Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2001 | 06-2001 | 03-2001 | 12-2000 | 09-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,204,600 | 1,634,500 | 806,800 | 3,057,800 | 2,290,500 |
| Depreciation Amortization | 377,300 | 247,800 | 120,400 | 435,800 | 359,900 |
| Income taxes - deferred | 246,400 | 158,000 | -22,400 | -442,700 | -74,900 |
| Accounts receivable | N/A | N/A | N/A | -165,400 | N/A |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | 1,143,800 | N/A |
| Other Working Capital | -390,500 | -513,200 | -412,600 | 777,700 | 206,200 |
| Other Operating Activity | 143,200 | 20,500 | 35,400 | -1,075,500 | -130,100 |
| Operating Cash Flow | $2,581,000 | $1,547,600 | $527,600 | $3,731,500 | $2,651,600 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | -337,700 | N/A |
| PPE Investments | -570,600 | -342,600 | -154,000 | -672,800 | -433,000 |
| Purchase Of Investment | -2,743,800 | -1,852,500 | -909,000 | -714,700 | -1,484,500 |
| Sale Of Investment | 30,500 | 4,900 | 15,900 | 803,100 | 534,700 |
| Other Investing Activity | -195,700 | -50,000 | -19,500 | -134,400 | -96,900 |
| Investing Cash Flow | $-3,479,600 | $-2,240,200 | $-1,066,600 | $-1,056,500 | $-1,479,700 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 255,100 | 247,300 | 249,900 | -203,000 | -191,400 |
| Debt Issued | 443,900 | 268,200 | 25,000 | 1,100 | -23,900 |
| Debt Repayment | N/A | N/A | N/A | -27,200 | N/A |
| Common Stock Issued | 83,400 | 85,400 | 42,700 | 178,400 | 124,500 |
| Common Stock Repurchased | -421,500 | -362,900 | -307,000 | -1,052,800 | -754,200 |
| Dividend Paid | -905,400 | -603,300 | -302,000 | -1,126,000 | -845,000 |
| Financing Cash Flow | $-544,500 | $-365,300 | $-291,400 | $-2,229,500 | $-1,690,000 |
| Exchange Rate Effect | -25,500 | -85,200 | -53,200 | -31,000 | -66,100 |
| Beginning Cash Position | 4,114,900 | 4,114,900 | 4,114,900 | 3,700,400 | 3,700,400 |
| End Cash Position | 2,646,300 | 2,971,800 | 3,231,300 | 4,114,900 | 3,116,200 |
| Net Cash Flow | $-1,468,600 | $-1,143,100 | $-883,600 | $414,500 | $-584,200 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,581,000 | 1,547,600 | 527,600 | 3,731,500 | 2,651,600 |
| Capital Expenditure | -570,600 | -342,600 | -154,000 | -677,900 | -433,000 |
| Free Cash Flow | 2,010,400 | 1,205,000 | 373,600 | 3,053,600 | 2,218,600 |